RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,107 | -24.8% | 40,369 | -38.4% | 0.02% | -42.3% |
| Q2 2023 | $161,109 | +8.9% | 65,491 | 0.0% | 0.03% | -23.5% |
| Q1 2023 | $148,010 | -35.2% | 65,491 | 0.0% | 0.03% | -38.2% |
| Q4 2022 | $228,563 | -99.6% | 65,491 | -95.8% | 0.06% | -99.5% |
| Q3 2022 | $57,404,000 | +419.0% | 1,550,600 | +166.3% | 11.44% | +467.1% |
| Q2 2022 | $11,060,000 | +1781.0% | 582,300 | +2571.0% | 2.02% | +2519.5% |
| Q1 2022 | $588,000 | +25.9% | 21,801 | +5.1% | 0.08% | +10.0% |
| Q4 2021 | $467,000 | -14.2% | 20,743 | 0.0% | 0.07% | +84.2% |
| Q3 2021 | $544,000 | -96.6% | 20,743 | -95.9% | 0.04% | -97.1% |
| Q2 2021 | $16,120,000 | -6.1% | 503,607 | +3.2% | 1.30% | +125.4% |
| Q1 2021 | $17,176,000 | +812.6% | 487,807 | +784.2% | 0.58% | +307.0% |
| Q1 2020 | $1,882,000 | – | 55,172 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |